The U.S. Food and Drug Administration (FDA) is alerting the public to the problems with using counterfeit One Touch Basic/Profile and One Touch Ultra Blood Glucose Test Strips. These products are used by people with diabetes to measure their blood glucose.
The counterfeit test strips could potentially give an incorrect blood glucose value – either too high or too low – which might result in a patient taking either too much or too little insulin. Taking the incorrect amount of insuling can lead to serious injury or death.
The counterfeit test strips are:
One Touch Basic or One Touch Profile (lot #272894A, 2619932 or 2606340) test strips; and, One Touch Ultra (lot #2691191) test strips.
Consumers who have the counterfeit test strips should stop using them, replace them immediately and contact their physician. Consumers with questions may contact the company at 1-866-621-4855.
The counterfeit test strips were distributed to pharmacies and stores nationwide–but primarily in Ohio, New York, Florida, Maryland and Missouri–by Medical Plastic Devices, Inc., Quebec, Canada and Champion Sales, Inc., Brooklyn, N.Y.
The counterfeit test strips can be identified by the following characteristics:
Counterfeit One Touch Basic/Profile Test Strips
Lot Numbers 272894A, 2619932 or 2606340
Multiple Languages- English, Greek and Portuguese text on the outer carton
Limited to 50-Count One Touch (Basic/Profile) Test Strip packages
Counterfeit One Touch Ultra Test Strips
Lot Number 2691191
Multiple Languages- English and French text on the outer carton
Limited to 50-Count One Touch Ultra Test Strip packages
LifeScan alerted FDA of the counterfeit test strips. The agency is investigating the matter.
LifeScan is alerting the public via a press release and is notifying pharmacists, distributors, and wholesalers through a letter. In its letter, the company is advising customers to contact their original source of supply for restitution. For more information, visit: www.GenuineOneTouch.com.
Any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA’s MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, by mail at MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD, 20852-9787, or through the MedWatch Web site at www.fda.gov/medwatch.